21-41991677-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001098402.2(ZBTB21):c.2419G>A(p.Glu807Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001098402.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB21 | NM_001098402.2 | c.2419G>A | p.Glu807Lys | missense_variant | 3/3 | ENST00000310826.10 | NP_001091872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB21 | ENST00000310826.10 | c.2419G>A | p.Glu807Lys | missense_variant | 3/3 | 1 | NM_001098402.2 | ENSP00000308759.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251452Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135906
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461884Hom.: 0 Cov.: 30 AF XY: 0.0000523 AC XY: 38AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.2419G>A (p.E807K) alteration is located in exon 3 (coding exon 1) of the ZBTB21 gene. This alteration results from a G to A substitution at nucleotide position 2419, causing the glutamic acid (E) at amino acid position 807 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at